-
1
-
-
41349089713
-
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
-
DOI 10.1182/blood-2007-06-094136
-
Brodsky, R.A., Young, N.S., Antonioli, E., Risitano, A.M., Schrezenmeier, H., Schubert, J., Gaya, A., Coyle, L., de Castro, C., Fu, C.L., Maciejewski, J.P., Bessler, M., Kroon, H.A., Rother, R.P. Hillmen, P. (2008) Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood, 111, 1840 1847. (Pubitemid 351451491)
-
(2008)
Blood
, vol.111
, Issue.4
, pp. 1840-1847
-
-
Brodsky, R.A.1
Young, N.S.2
Antonioli, E.3
Risitano, A.M.4
Schrezenmeier, H.5
Schubert, J.6
Gaya, A.7
Coyle, L.8
De Castro, C.9
Fu, C.-L.10
Maciejewski, J.P.11
Bessler, M.12
Kroon, H.-A.13
Rother, R.P.14
Hillmen, P.15
-
2
-
-
10744225308
-
Production of interferon-gamma by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: Relationship with clinical status
-
Coluzzi, S., Biffoni, M., Pasqualetti, D., Perrone, M.P., Vaglio, S., Rahimi, H., Arista, M.C., Laurenti, L., Cerretti, R. Girelli, G. (2004) Production of interferon-gamma by lymphocytes from paroxysmal nocturnal haemoglobinuria patients: relationship with clinical status. British Journal of Haematology, 124, 685 690.
-
(2004)
British Journal of Haematology
, vol.124
, pp. 685-690
-
-
Coluzzi, S.1
Biffoni, M.2
Pasqualetti, D.3
Perrone, M.P.4
Vaglio, S.5
Rahimi, H.6
Arista, M.C.7
Laurenti, L.8
Cerretti, R.9
Girelli, G.10
-
3
-
-
18244426909
-
Plasmatic coagulation and fibrinolytic alterations in PNH: Relation to clone size
-
Grunewald, M., Siegemund, A., Grunewald, A., Schmid, A., Koksch, M. Schopflin, C. (2003) Plasmatic coagulation and fibrinolytic alterations in PNH: relation to clone size. Blood Coagulation and Fibrinolysis, 14, 685 695.
-
(2003)
Blood Coagulation and Fibrinolysis
, vol.14
, pp. 685-695
-
-
Grunewald, M.1
Siegemund, A.2
Grunewald, A.3
Schmid, A.4
Koksch, M.5
Schopflin, C.6
-
4
-
-
68949202584
-
NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes
-
Hanaoka, N., Nakakuma, H., Horikawa, K., Nagakura, S., Tsuzuki, Y., Shimanuki, M., Kojima, K., Yonemura, Y. Kawagusci, T. (2009) NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes. British Journal of Haematology, 146, 538 545.
-
(2009)
British Journal of Haematology
, vol.146
, pp. 538-545
-
-
Hanaoka, N.1
Nakakuma, H.2
Horikawa, K.3
Nagakura, S.4
Tsuzuki, Y.5
Shimanuki, M.6
Kojima, K.7
Yonemura, Y.8
Kawagusci, T.9
-
5
-
-
0028802443
-
Natural history of paroxysmal nocturnal hemoglobinuria
-
Hillmen, P., Lewis, S.M., Bessler, M., Luzzatto, L. Dacie, J.V. (1995) Natural history of paroxysmal nocturnal hemoglobinuria. New England Journal of Medicine, 333, 1253 1258.
-
(1995)
New England Journal of Medicine
, vol.333
, pp. 1253-1258
-
-
Hillmen, P.1
Lewis, S.M.2
Bessler, M.3
Luzzatto, L.4
Dacie, J.V.5
-
6
-
-
35948962168
-
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
-
DOI 10.1182/blood-2007-06-095646
-
Hillmen, P., Muus, P., Duhrsen, U., Risitano, A.M., Schulbert, J., Luzzatto, L., Schrezenmeier, H., Szer, J., Brodsky, R.A., Hill, A., Socié, G., Bessler, M., Rollins, S.A., Bell, L., Rother, R.P. Young, N.S. (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood, 110, 4123 4128. (Pubitemid 350248472)
-
(2007)
Blood
, vol.110
, Issue.12
, pp. 4123-4128
-
-
Hillmen, P.1
Muus, P.2
Duhrsen, U.3
Risitano, A.M.4
Schubert, J.5
Luzzatto, L.6
Schrezenmeier, H.7
Szer, J.8
Brodsky, R.A.9
Hill, A.10
Socie, G.11
Bessler, M.12
Rollins, S.A.13
Bell, L.14
Rother, R.P.15
Young, N.S.16
-
7
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospolipid syndrome (APS)
-
Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, L., Cervera, R., Derksen, R.H.W.M., De Groot, P.G., Koike, T., Meroni, L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospolipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295 306.
-
(2006)
Journal of Thrombosis and Haemostasis
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
Branch, D.W.4
Brey, L.5
Cervera, R.6
Derksen, R.H.W.M.7
De Groot, P.G.8
Koike, T.9
Meroni, L.10
Reber, G.11
Shoenfeld, Y.12
Tincani, A.13
Vlachoyiannopoulos, P.G.14
Krilis, S.A.15
-
8
-
-
70350004861
-
Update of the guidelines for lupus anticoagulant detection
-
Pengo, V., Tripodi, A., Reber, G., Rand, H., Ortel, L., Galli, M. De Groot, P.G. (2009) Update of the guidelines for lupus anticoagulant detection. Journal of Thrombosis and Haemostasis, 7, 1737 1740.
-
(2009)
Journal of Thrombosis and Haemostasis
, vol.7
, pp. 1737-1740
-
-
Pengo, V.1
Tripodi, A.2
Reber, G.3
Rand, H.4
Ortel, L.5
Galli, M.6
De Groot, P.G.7
-
9
-
-
0033974579
-
The molecular basis of paroxysmal nocturnal hemoglobinuria
-
Rosti, V. (2000) The molecular basis of paroxysmal nocturnal hemoglobinuria. Haematologica, 85, 82 87.
-
(2000)
Haematologica
, vol.85
, pp. 82-87
-
-
Rosti, V.1
-
10
-
-
16044365965
-
Paroxysmal nocturnal haemoglobinuria: Long term follow-up and prognostic factors
-
Socie, G., Gramont, A., Rio, B., Leporrier, M., Rose, C., Heudier, P., Rochant, H., Cahn, J.Y. Gluckman, E. (1996) Paroxysmal nocturnal haemoglobinuria: long term follow-up and prognostic factors. Lancet, 348, 573 577.
-
(1996)
Lancet
, vol.348
, pp. 573-577
-
-
Socie, G.1
Gramont, A.2
Rio, B.3
Leporrier, M.4
Rose, C.5
Heudier, P.6
Rochant, H.7
Cahn, J.Y.8
Gluckman, E.9
|